SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-20-007869
Filing Date
2020-05-07
Accepted
2020-05-07 07:31:14
Documents
75
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 435112
2 ex4-1.htm EX-4.1 153549
3 ex4-2.htm EX-4.2 152767
4 ex10-1.htm EX-10.1 80073
5 ex31-1.htm EX-31.1 14648
6 ex31-2.htm EX-31.2 17907
7 ex32-1.htm EX-32.1 6618
8 ex32-2.htm EX-32.2 6660
  Complete submission text file 0001493152-20-007869.txt   3096792

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE xtnt-20200331.xml EX-101.INS 353124
10 XBRL SCHEMA FILE xtnt-20200331.xsd EX-101.SCH 41719
11 XBRL CALCULATION FILE xtnt-20200331_cal.xml EX-101.CAL 67850
12 XBRL DEFINITION FILE xtnt-20200331_def.xml EX-101.DEF 98183
13 XBRL LABEL FILE xtnt-20200331_lab.xml EX-101.LAB 276890
14 XBRL PRESENTATION FILE xtnt-20200331_pre.xml EX-101.PRE 204178
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

IRS No.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 20854576
SIC: 2836 Biological Products, (No Diagnostic Substances)